nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenazopyridine—SCN10A—skin cancer	0.889	1	CbGaD
Phenazopyridine—SCN7A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00594	0.0821	CbGpPWpGaD
Phenazopyridine—SCN11A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00529	0.0732	CbGpPWpGaD
Phenazopyridine—SCN8A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00484	0.067	CbGpPWpGaD
Phenazopyridine—SCN11A—nerve—skin cancer	0.00422	0.219	CbGeAlD
Phenazopyridine—SCN9A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00391	0.0542	CbGpPWpGaD
Phenazopyridine—SCN3A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00374	0.0518	CbGpPWpGaD
Phenazopyridine—SCN4A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.0036	0.0498	CbGpPWpGaD
Phenazopyridine—SCN2A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.0036	0.0498	CbGpPWpGaD
Phenazopyridine—SCN1A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00347	0.048	CbGpPWpGaD
Phenazopyridine—SCN8A—nerve—skin cancer	0.0032	0.166	CbGeAlD
Phenazopyridine—SCN5A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00244	0.0337	CbGpPWpGaD
Phenazopyridine—SCN7A—L1CAM interactions—SCN10A—skin cancer	0.00228	0.0315	CbGpPWpGaD
Phenazopyridine—SCN10A—nerve—skin cancer	0.00214	0.111	CbGeAlD
Phenazopyridine—SCN11A—L1CAM interactions—SCN10A—skin cancer	0.00203	0.0281	CbGpPWpGaD
Phenazopyridine—SCN8A—L1CAM interactions—SCN10A—skin cancer	0.00186	0.0257	CbGpPWpGaD
Phenazopyridine—SCN9A—L1CAM interactions—SCN10A—skin cancer	0.0015	0.0208	CbGpPWpGaD
Phenazopyridine—SCN3A—L1CAM interactions—SCN10A—skin cancer	0.00144	0.0199	CbGpPWpGaD
Phenazopyridine—SCN2A—L1CAM interactions—SCN10A—skin cancer	0.00138	0.0191	CbGpPWpGaD
Phenazopyridine—SCN4A—L1CAM interactions—SCN10A—skin cancer	0.00138	0.0191	CbGpPWpGaD
Phenazopyridine—SCN1A—L1CAM interactions—SCN10A—skin cancer	0.00133	0.0184	CbGpPWpGaD
Phenazopyridine—SCN7A—female reproductive system—skin cancer	0.00102	0.053	CbGeAlD
Phenazopyridine—Digestion impaired—Temozolomide—skin cancer	0.00101	0.0506	CcSEcCtD
Phenazopyridine—SCN11A—head—skin cancer	0.001	0.052	CbGeAlD
Phenazopyridine—SCN5A—L1CAM interactions—SCN10A—skin cancer	0.000936	0.0129	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—SCN10A—skin cancer	0.000861	0.0119	CbGpPWpGaD
Phenazopyridine—SCN7A—head—skin cancer	0.000851	0.0442	CbGeAlD
Phenazopyridine—SCN11A—Axon guidance—SCN10A—skin cancer	0.000768	0.0106	CbGpPWpGaD
Phenazopyridine—SCN8A—head—skin cancer	0.000759	0.0394	CbGeAlD
Phenazopyridine—SCN8A—Axon guidance—SCN10A—skin cancer	0.000702	0.00971	CbGpPWpGaD
Phenazopyridine—Dyspepsia—Vismodegib—skin cancer	0.00067	0.0336	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Vismodegib—skin cancer	0.000657	0.033	CcSEcCtD
Phenazopyridine—SCN10A—lymphoid tissue—skin cancer	0.00063	0.0327	CbGeAlD
Phenazopyridine—SCN7A—Developmental Biology—SCN10A—skin cancer	0.000614	0.0085	CbGpPWpGaD
Phenazopyridine—SCN7A—lymph node—skin cancer	0.000596	0.031	CbGeAlD
Phenazopyridine—SCN4A—head—skin cancer	0.000595	0.0309	CbGeAlD
Phenazopyridine—SCN1A—head—skin cancer	0.000574	0.0298	CbGeAlD
Phenazopyridine—SCN9A—Axon guidance—SCN10A—skin cancer	0.000568	0.00785	CbGpPWpGaD
Phenazopyridine—SCN3A—female reproductive system—skin cancer	0.000554	0.0288	CbGeAlD
Phenazopyridine—SCN11A—Developmental Biology—SCN10A—skin cancer	0.000548	0.00758	CbGpPWpGaD
Phenazopyridine—Visual impairment—Imiquimod—skin cancer	0.000544	0.0273	CcSEcCtD
Phenazopyridine—SCN3A—Axon guidance—SCN10A—skin cancer	0.000543	0.00751	CbGpPWpGaD
Phenazopyridine—Pruritus—Vismodegib—skin cancer	0.000538	0.027	CcSEcCtD
Phenazopyridine—SCN2A—head—skin cancer	0.000526	0.0274	CbGeAlD
Phenazopyridine—SCN2A—Axon guidance—SCN10A—skin cancer	0.000522	0.00722	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—SCN10A—skin cancer	0.000522	0.00722	CbGpPWpGaD
Phenazopyridine—Diarrhoea—Vismodegib—skin cancer	0.000521	0.0262	CcSEcCtD
Phenazopyridine—SCN10A—head—skin cancer	0.000508	0.0264	CbGeAlD
Phenazopyridine—SCN1A—Axon guidance—SCN10A—skin cancer	0.000503	0.00696	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—SCN10A—skin cancer	0.000501	0.00693	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—RASA1—skin cancer	0.000495	0.00684	CbGpPWpGaD
Phenazopyridine—Vomiting—Vismodegib—skin cancer	0.000484	0.0243	CcSEcCtD
Phenazopyridine—Rash—Vismodegib—skin cancer	0.00048	0.0241	CcSEcCtD
Phenazopyridine—Dermatitis—Vismodegib—skin cancer	0.000479	0.0241	CcSEcCtD
Phenazopyridine—SCN9A—lymph node—skin cancer	0.000467	0.0243	CbGeAlD
Phenazopyridine—SCN3A—head—skin cancer	0.000463	0.024	CbGeAlD
Phenazopyridine—SCN5A—head—skin cancer	0.000461	0.024	CbGeAlD
Phenazopyridine—Nausea—Vismodegib—skin cancer	0.000452	0.0227	CcSEcCtD
Phenazopyridine—SCN11A—Axon guidance—RASA1—skin cancer	0.000441	0.0061	CbGpPWpGaD
Phenazopyridine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.000406	0.0204	CcSEcCtD
Phenazopyridine—SCN9A—Developmental Biology—SCN10A—skin cancer	0.000405	0.00561	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—RASA1—skin cancer	0.000403	0.00558	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—SCN10A—skin cancer	0.000388	0.00536	CbGpPWpGaD
Phenazopyridine—Hepatitis—Dactinomycin—skin cancer	0.000374	0.0188	CcSEcCtD
Phenazopyridine—SCN4A—Developmental Biology—SCN10A—skin cancer	0.000372	0.00515	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—SCN10A—skin cancer	0.000372	0.00515	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—SCN10A—skin cancer	0.000359	0.00497	CbGpPWpGaD
Phenazopyridine—SCN10A—lymph node—skin cancer	0.000355	0.0185	CbGeAlD
Phenazopyridine—SCN5A—Axon guidance—SCN10A—skin cancer	0.000354	0.00489	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—RASA1—skin cancer	0.000353	0.00488	CbGpPWpGaD
Phenazopyridine—Dyspepsia—Imiquimod—skin cancer	0.000353	0.0177	CcSEcCtD
Phenazopyridine—Hypersensitivity—Vemurafenib—skin cancer	0.000346	0.0174	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Imiquimod—skin cancer	0.000346	0.0174	CcSEcCtD
Phenazopyridine—Visual disturbance—Docetaxel—skin cancer	0.000343	0.0172	CcSEcCtD
Phenazopyridine—Hepatitis—Temozolomide—skin cancer	0.000338	0.017	CcSEcCtD
Phenazopyridine—Pruritus—Vemurafenib—skin cancer	0.000333	0.0167	CcSEcCtD
Phenazopyridine—SCN9A—Axon guidance—RASA1—skin cancer	0.000326	0.00451	CbGpPWpGaD
Phenazopyridine—Visual impairment—Temozolomide—skin cancer	0.000326	0.0164	CcSEcCtD
Phenazopyridine—SCN3A—lymph node—skin cancer	0.000324	0.0168	CbGeAlD
Phenazopyridine—Diarrhoea—Vemurafenib—skin cancer	0.000322	0.0162	CcSEcCtD
Phenazopyridine—SCN11A—Developmental Biology—RASA1—skin cancer	0.000315	0.00435	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—RASA1—skin cancer	0.000312	0.00432	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—RASA1—skin cancer	0.0003	0.00415	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—RASA1—skin cancer	0.0003	0.00415	CbGpPWpGaD
Phenazopyridine—Vomiting—Vemurafenib—skin cancer	0.000299	0.015	CcSEcCtD
Phenazopyridine—Rash—Vemurafenib—skin cancer	0.000296	0.0149	CcSEcCtD
Phenazopyridine—Dermatitis—Vemurafenib—skin cancer	0.000296	0.0149	CcSEcCtD
Phenazopyridine—Hypersensitivity—Imiquimod—skin cancer	0.000295	0.0148	CcSEcCtD
Phenazopyridine—Headache—Vemurafenib—skin cancer	0.000294	0.0148	CcSEcCtD
Phenazopyridine—SCN10A—Axon guidance—RASA1—skin cancer	0.000289	0.004	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—RASA1—skin cancer	0.000289	0.004	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—RASA1—skin cancer	0.000288	0.00398	CbGpPWpGaD
Phenazopyridine—Pruritus—Imiquimod—skin cancer	0.000284	0.0142	CcSEcCtD
Phenazopyridine—Nausea—Vemurafenib—skin cancer	0.000279	0.014	CcSEcCtD
Phenazopyridine—Diarrhoea—Imiquimod—skin cancer	0.000274	0.0138	CcSEcCtD
Phenazopyridine—Vomiting—Imiquimod—skin cancer	0.000255	0.0128	CcSEcCtD
Phenazopyridine—Rash—Imiquimod—skin cancer	0.000253	0.0127	CcSEcCtD
Phenazopyridine—Dermatitis—Imiquimod—skin cancer	0.000253	0.0127	CcSEcCtD
Phenazopyridine—SCN5A—Developmental Biology—SCN10A—skin cancer	0.000252	0.00349	CbGpPWpGaD
Phenazopyridine—Headache—Imiquimod—skin cancer	0.000251	0.0126	CcSEcCtD
Phenazopyridine—Jaundice—Docetaxel—skin cancer	0.000244	0.0123	CcSEcCtD
Phenazopyridine—Nausea—Imiquimod—skin cancer	0.000238	0.012	CcSEcCtD
Phenazopyridine—SCN9A—Developmental Biology—RASA1—skin cancer	0.000233	0.00322	CbGpPWpGaD
Phenazopyridine—Hepatitis—Docetaxel—skin cancer	0.000225	0.0113	CcSEcCtD
Phenazopyridine—SCN3A—Developmental Biology—RASA1—skin cancer	0.000223	0.00308	CbGpPWpGaD
Phenazopyridine—Visual impairment—Docetaxel—skin cancer	0.000217	0.0109	CcSEcCtD
Phenazopyridine—SCN2A—Developmental Biology—RASA1—skin cancer	0.000214	0.00296	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—RASA1—skin cancer	0.000214	0.00296	CbGpPWpGaD
Phenazopyridine—Dyspepsia—Temozolomide—skin cancer	0.000211	0.0106	CcSEcCtD
Phenazopyridine—Hypersensitivity—Bleomycin—skin cancer	0.00021	0.0105	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000207	0.0104	CcSEcCtD
Phenazopyridine—SCN1A—Developmental Biology—RASA1—skin cancer	0.000206	0.00285	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—RASA1—skin cancer	0.000206	0.00285	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—RASA1—skin cancer	0.000203	0.00281	CbGpPWpGaD
Phenazopyridine—Pruritus—Bleomycin—skin cancer	0.000201	0.0101	CcSEcCtD
Phenazopyridine—Hypersensitivity—Dactinomycin—skin cancer	0.000196	0.00983	CcSEcCtD
Phenazopyridine—Dyspepsia—Fluorouracil—skin cancer	0.000195	0.00979	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000191	0.0096	CcSEcCtD
Phenazopyridine—Diarrhoea—Dactinomycin—skin cancer	0.000182	0.00913	CcSEcCtD
Phenazopyridine—Vomiting—Bleomycin—skin cancer	0.000181	0.0091	CcSEcCtD
Phenazopyridine—Rash—Bleomycin—skin cancer	0.00018	0.00902	CcSEcCtD
Phenazopyridine—Dermatitis—Bleomycin—skin cancer	0.000179	0.00901	CcSEcCtD
Phenazopyridine—Hypersensitivity—Temozolomide—skin cancer	0.000177	0.00889	CcSEcCtD
Phenazopyridine—SCN7A—Developmental Biology—CDK4—skin cancer	0.000173	0.00239	CbGpPWpGaD
Phenazopyridine—Pruritus—Temozolomide—skin cancer	0.00017	0.00854	CcSEcCtD
Phenazopyridine—Nausea—Bleomycin—skin cancer	0.000169	0.0085	CcSEcCtD
Phenazopyridine—Vomiting—Dactinomycin—skin cancer	0.000169	0.00848	CcSEcCtD
Phenazopyridine—Rash—Dactinomycin—skin cancer	0.000167	0.00841	CcSEcCtD
Phenazopyridine—Diarrhoea—Temozolomide—skin cancer	0.000164	0.00826	CcSEcCtD
Phenazopyridine—Hypersensitivity—Fluorouracil—skin cancer	0.000163	0.00819	CcSEcCtD
Phenazopyridine—Nausea—Dactinomycin—skin cancer	0.000158	0.00793	CcSEcCtD
Phenazopyridine—Pruritus—Fluorouracil—skin cancer	0.000157	0.00787	CcSEcCtD
Phenazopyridine—SCN11A—Developmental Biology—CDK4—skin cancer	0.000154	0.00213	CbGpPWpGaD
Phenazopyridine—Vomiting—Temozolomide—skin cancer	0.000153	0.00767	CcSEcCtD
Phenazopyridine—Rash—Temozolomide—skin cancer	0.000151	0.00761	CcSEcCtD
Phenazopyridine—Diarrhoea—Fluorouracil—skin cancer	0.000151	0.00761	CcSEcCtD
Phenazopyridine—Dermatitis—Temozolomide—skin cancer	0.000151	0.0076	CcSEcCtD
Phenazopyridine—Headache—Temozolomide—skin cancer	0.000151	0.00756	CcSEcCtD
Phenazopyridine—SCN5A—Developmental Biology—RASA1—skin cancer	0.000145	0.00201	CbGpPWpGaD
Phenazopyridine—Nausea—Temozolomide—skin cancer	0.000143	0.00717	CcSEcCtD
Phenazopyridine—SCN8A—Developmental Biology—CDK4—skin cancer	0.000141	0.00195	CbGpPWpGaD
Phenazopyridine—Vomiting—Fluorouracil—skin cancer	0.000141	0.00707	CcSEcCtD
Phenazopyridine—Dyspepsia—Docetaxel—skin cancer	0.000141	0.00706	CcSEcCtD
Phenazopyridine—Rash—Fluorouracil—skin cancer	0.00014	0.00701	CcSEcCtD
Phenazopyridine—Dermatitis—Fluorouracil—skin cancer	0.000139	0.007	CcSEcCtD
Phenazopyridine—Headache—Fluorouracil—skin cancer	0.000139	0.00697	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Docetaxel—skin cancer	0.000138	0.00693	CcSEcCtD
Phenazopyridine—SCN7A—Axon guidance—NRAS—skin cancer	0.000135	0.00187	CbGpPWpGaD
Phenazopyridine—Nausea—Fluorouracil—skin cancer	0.000131	0.0066	CcSEcCtD
Phenazopyridine—SCN11A—Axon guidance—NRAS—skin cancer	0.00012	0.00166	CbGpPWpGaD
Phenazopyridine—Hypersensitivity—Docetaxel—skin cancer	0.000118	0.00591	CcSEcCtD
Phenazopyridine—SCN7A—Axon guidance—KRAS—skin cancer	0.000116	0.00161	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—CDK4—skin cancer	0.000114	0.00158	CbGpPWpGaD
Phenazopyridine—Pruritus—Docetaxel—skin cancer	0.000113	0.00568	CcSEcCtD
Phenazopyridine—SCN8A—Axon guidance—NRAS—skin cancer	0.00011	0.00152	CbGpPWpGaD
Phenazopyridine—Diarrhoea—Docetaxel—skin cancer	0.000109	0.00549	CcSEcCtD
Phenazopyridine—SCN3A—Developmental Biology—CDK4—skin cancer	0.000109	0.00151	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—CDK4—skin cancer	0.000105	0.00145	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—CDK4—skin cancer	0.000105	0.00145	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—KRAS—skin cancer	0.000103	0.00143	CbGpPWpGaD
Phenazopyridine—Vomiting—Docetaxel—skin cancer	0.000102	0.0051	CcSEcCtD
Phenazopyridine—SCN10A—Developmental Biology—CDK4—skin cancer	0.000101	0.0014	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—CDK4—skin cancer	0.000101	0.0014	CbGpPWpGaD
Phenazopyridine—Rash—Docetaxel—skin cancer	0.000101	0.00506	CcSEcCtD
Phenazopyridine—Dermatitis—Docetaxel—skin cancer	0.000101	0.00506	CcSEcCtD
Phenazopyridine—Headache—Docetaxel—skin cancer	0.0001	0.00503	CcSEcCtD
Phenazopyridine—SCN7A—Axon guidance—HRAS—skin cancer	9.87e-05	0.00137	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—NRAS—skin cancer	9.62e-05	0.00133	CbGpPWpGaD
Phenazopyridine—Nausea—Docetaxel—skin cancer	9.49e-05	0.00477	CcSEcCtD
Phenazopyridine—SCN8A—Axon guidance—KRAS—skin cancer	9.46e-05	0.00131	CbGpPWpGaD
Phenazopyridine—SCN7A—Axon guidance—IL6—skin cancer	9.44e-05	0.00131	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—NRAS—skin cancer	8.89e-05	0.00123	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—HRAS—skin cancer	8.79e-05	0.00122	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—NRAS—skin cancer	8.58e-05	0.00119	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—NRAS—skin cancer	8.51e-05	0.00118	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—IL6—skin cancer	8.42e-05	0.00116	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—KRAS—skin cancer	8.28e-05	0.00115	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—NRAS—skin cancer	8.17e-05	0.00113	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—NRAS—skin cancer	8.17e-05	0.00113	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—HRAS—skin cancer	8.04e-05	0.00111	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—NRAS—skin cancer	7.88e-05	0.00109	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—NRAS—skin cancer	7.88e-05	0.00109	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—NRAS—skin cancer	7.85e-05	0.00109	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—IL6—skin cancer	7.7e-05	0.00107	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—KRAS—skin cancer	7.65e-05	0.00106	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—KRAS—skin cancer	7.38e-05	0.00102	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—KRAS—skin cancer	7.32e-05	0.00101	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—CDK4—skin cancer	7.11e-05	0.000984	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—HRAS—skin cancer	7.04e-05	0.000974	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—KRAS—skin cancer	7.03e-05	0.000973	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—KRAS—skin cancer	7.03e-05	0.000973	CbGpPWpGaD
Phenazopyridine—SCN5A—SIDS Susceptibility Pathways—IL6—skin cancer	6.96e-05	0.000963	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—KRAS—skin cancer	6.78e-05	0.000938	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—KRAS—skin cancer	6.78e-05	0.000938	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—KRAS—skin cancer	6.75e-05	0.000934	CbGpPWpGaD
Phenazopyridine—SCN7A—Developmental Biology—IL6—skin cancer	6.74e-05	0.000932	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—HRAS—skin cancer	6.51e-05	0.0009	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—NRAS—skin cancer	6.35e-05	0.000878	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—HRAS—skin cancer	6.28e-05	0.000868	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—IL6—skin cancer	6.23e-05	0.000861	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—HRAS—skin cancer	6.22e-05	0.000861	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—NRAS—skin cancer	6.07e-05	0.00084	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—IL6—skin cancer	6.01e-05	0.000831	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—HRAS—skin cancer	5.98e-05	0.000827	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—HRAS—skin cancer	5.98e-05	0.000827	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—IL6—skin cancer	5.96e-05	0.000824	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—NRAS—skin cancer	5.83e-05	0.000807	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—NRAS—skin cancer	5.83e-05	0.000807	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—HRAS—skin cancer	5.76e-05	0.000798	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—HRAS—skin cancer	5.76e-05	0.000798	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—HRAS—skin cancer	5.74e-05	0.000794	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—IL6—skin cancer	5.72e-05	0.000792	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—IL6—skin cancer	5.72e-05	0.000792	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—NRAS—skin cancer	5.62e-05	0.000778	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—NRAS—skin cancer	5.62e-05	0.000778	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—NRAS—skin cancer	5.54e-05	0.000766	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—IL6—skin cancer	5.52e-05	0.000763	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—IL6—skin cancer	5.52e-05	0.000763	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—IL6—skin cancer	5.49e-05	0.00076	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—KRAS—skin cancer	5.46e-05	0.000756	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—KRAS—skin cancer	5.22e-05	0.000723	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—KRAS—skin cancer	5.02e-05	0.000694	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—KRAS—skin cancer	5.02e-05	0.000694	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—KRAS—skin cancer	4.84e-05	0.00067	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—KRAS—skin cancer	4.84e-05	0.00067	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—KRAS—skin cancer	4.77e-05	0.00066	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—HRAS—skin cancer	4.64e-05	0.000642	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—IL6—skin cancer	4.44e-05	0.000615	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—HRAS—skin cancer	4.44e-05	0.000614	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—HRAS—skin cancer	4.27e-05	0.00059	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—HRAS—skin cancer	4.27e-05	0.00059	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—IL6—skin cancer	4.25e-05	0.000588	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—HRAS—skin cancer	4.11e-05	0.000569	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—HRAS—skin cancer	4.11e-05	0.000569	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—IL6—skin cancer	4.08e-05	0.000565	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—IL6—skin cancer	4.08e-05	0.000565	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—HRAS—skin cancer	4.05e-05	0.000561	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—NRAS—skin cancer	3.95e-05	0.000547	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—IL6—skin cancer	3.94e-05	0.000545	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—IL6—skin cancer	3.94e-05	0.000545	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—IL6—skin cancer	3.88e-05	0.000537	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—KRAS—skin cancer	3.4e-05	0.000471	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—HRAS—skin cancer	2.89e-05	0.0004	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—IL6—skin cancer	2.77e-05	0.000383	CbGpPWpGaD
